APPLICATIONS PUBLISHED 16 OCTOBER 2002
Published: 1-Apr-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Treatment of UV-induced immunosuppression
Grigg, Geoffrey Walter 1248593*
Multi-spike release formulation for drug delivery
Pharmaceutical Discovery Corp 1248594*
Multi-step drug dosage forms
Delsys Pharmaceutical Corp 1248595*
Implantation kit comprising a support phase and a solvent
Bodmeier, Roland 1248596*
Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
Glaxo Group 1248597*
Osmotic device having a preformed passageway that increases in size
Osmotica 1248598*
Multi-particulate form of medicament, comprising at least two differently coated forms of pellet
Roehm 1248599*
Improved pharmaceutical formulations
Abbott Laboratories 1248600*
Control of microbial populations in the gastoinestinal tract of animals
Lynntech 1248601*
Use of retinoid receptor antagonists in the treatment of cartilage and bone pathologies
Allergan 1248602*
Use of particular compounds for prophylaxis and treatment of hepatitis C
Morphochem 1248603*
Combinations comprising dipeptidyl-peptidase-IV inhibitors and anti-diabetic agents
Novartis 1248604*
Novel sertraline hydrochloride polymorphs, processes for preparing them, compsns containing them and methods of using them
Teva Pharmaceuticals 1248605*
Use of fumaric acid derivatives for treating mitochondrial diseases
Fumapharm 1248606*
Urotensin-II receptor antagonists
SmithKline Beecham 1248607*
Substances for use in treating psoriasis
Laboratoires Medidom 1248608*
Method of treating benign forgetfulness
Juvenon 1248609*
Use of at least a fatty ester for preparing a compsn designed to inhibit 5-alpha-reductase activity, in pharmacology, in particular dermatology, in cosmetics and as a food additive
Laboratoires Pharmoscience 1248610*
Inhibition of two-component signal transduction systems
Unisearch 1248611*
Novel compounds and compsns as protease inhibitors
Merck Frosst Canada; Axys Pharmaceuticals 1248612*
Clonidine preparations
Curatex Pharmaceuticals 1248613*
Non-peptide inhibition of T-lymphocyte activation and therapies related thereto
The Regents of the University of California 1248614*
Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
Alteon 1248615*
Functional coating of linezoid microcapsules for oral administration
Eurand America 1248616*
2-aza-bicyclo[ 2.2.2]octane NMDA/NR2B antagonists
Merck 1248617*
Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulphonyphenyl)-6'-methyl-2,3']bipyridinyl
Merck Frosst Canada; Merck 1248618*
Amorphous paroxetine compsn
Pentech Pharmaceuticals 1248619*
A new use of levosimendan
Orion 1248620*
Method and compsn for the treatment of pain
AstraZeneca 1248621*
Anxiety method
Bristol-Myers Squibb 1248622*
Treatment of diabetic ulcers
Pfizer 1248623*
3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
SmithKline Beecham 1248624*
Use of methylol-containing compounds for the manufacture of a medicament for the treatment of tumours
Rhode Island Hospital 1248625*
Pharmaceutical compsns containing steroidal structures and uses thereof
Sterix 1248626*
Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action
Assistance Publique Hopitaux de Paris 1248627*
Phospholipid compounds as anti-inflammation agents
Sky High 1248628*
Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxins by inhalation of antiendotoxin drugs
Eisai 1248629*
Compsn, in particular cosmetic or dermatological compsn, containing oligosaccharides and preparation method and cosmetic treatment method
Laboratoires G Pharm 1248630*
Methods for inhibiting/treating HIV infections and AIDS related symptoms
Therex Technologies 1248631*
Combinations of adenosine A1 agonist with an opioid and their use in the treatment of pain
Glaxo GrouP 1248632*
Antisense modulation of glycogen synthase kinase 3 beta expression
Isis Pharmaceuticals 1248633*
Antisense modulation of MEKK2 expression
Isis Pharmaceuticals 1248634*
Antisense modulation of glycogen synthase kinase 3 alpha expression
Isis Pharmaceuticals 1248635*
Dextrin containing compsns for prevention of adhesions
ML Laboratories 1248636*
Pharmaceutical compsn comprising pectin effective in inhibiting the male reproductive toxicity
Korea New Science Technical Centre 1248637*
Novel therapeutic use of enoxaparin
Aventis Pharma 1248638*
Hyaluronan product and process for manufacturing thereof
Bio-Hyos 1248639*
Preparation and xenotransplantation of porcine islets
Diatranz 1248640*
Use of EMAP II receptor antagonist compsn for treating pulmonary hypertension
Children's Hospital of Los Angeles 1248641*
VEGF-D/VEGF-C/VEGF peptidomimetic inhibitor
Ludwig Institute of Cancer Research 1248642*
The use of copolymer 1 and related peptides and polypeptides and T-cells treated therewith for neuroprotective therapy
Yeda Research and Development 1248643*
Method for enhancing the presentation of exogenous anitgen bu human antigen-presenting cells and opsonised micro particle complexes for applying this
IDM Immuno-Designed Molecules; Institut National de la Sante et de la Recherche Medicale; Institut National de la Recherche Scientifique 1248644*
Novel chimeric proteins and methods for using the same
TR Associates 1248645*
Compsns and vaccines containing antigen(s) of Cryptosporidium parvum and other enteric pathogen
Merial 1248646*
Outer membrane vesicle (OMV) vaccine comprising N. Meningitidis serogroup B outer membrane proteins
Chiron Spa 1248647*
Use of hemicellulose microparticles as vaccine adjuvant
Cambridge Biopolymers 1248649*
Product comprising a heterotrimeric G protein signal transduction inhibitor associated with antihypertensive agent for therapeutic use in the treatment of arterial hypertension
Societe de Conseils de Recherches et d'Applications Scientifiques 1248651*
Stable aqueous deoxyfructosazine solution
Aventis Pharma 1248652*
Gene therapy to promote angiogenesis and/or the pretreatment of heart failure
Stichting Klinische Farmacologie Groningen 1248653*
Intra-tumoral administration of IL-12 encoding nucleic acid molecules
Universitaet Zuerich Institut fuer Medizinische Virologie 1248654*
